["{\"step_by_step_thinking\": \"The question is about a new drug combination of chemotherapy and immunotherapy for metastatic melanoma. The relevant documents describe the use of chemotherapeutic agents in combination with immunotherapy to improve survival rates in various types of cancer, including acute leukemia. Since the current situation is prolonging survival, it is likely related to the positive outcomes described in the documents. Therefore, we can infer that the prevalence of metastatic melanoma would increase, as more patients survive and are diagnosed with the disease.\", \"answer_choice\": \"B\"}"]